Chapter 1. Research Objective
1.1 Objective, Definition & Scope
1.2 Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.2.3 Market Forecast - Estimation & Approach
1.2.4 Assumptions & Assessments
1.3 Insights and Growth - Relevancy Mapping
1.3.1 FABRIC Platform
1.4 Data mining & efficiency
Chapter 2. Executive Summary
2.1 Paediatric Genetic Testing Market Overview
2.2 Interconnectivity & Related markets
2.3 Ecosystem Map
2.4 Paediatric Genetic Testing Market Business Segmentation
2.5 Paediatric Genetic Testing Market Geographic Segmentation
2.6 Competition Outlook
2.7 Key Statistics
Chapter 3. Strategic Analysis
3.1 Paediatric Genetic Testing Market Revenue Opportunities
3.2 Cost Optimization
3.3 Covid19 aftermath - Analyst view
3.4 Paediatric Genetic Testing Market Digital Transformation
Chapter 4. Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PEST Analysis
4.2.1 Political
4.2.2 Economic
4.2.3 Social
4.2.4 Technological
4.3 Market Impacting Trends
4.3.1 Positive Impact Trends
4.3.2 Adverse Impact Trends
4.4 Porter's 5-force Analysis
4.5 Market News - By Segments
4.5.1 Organic News
4.5.2 Inorganic News
Chapter 5. Market Segmentation
The Paediatric Genetic Testing Market has been analysed to include the below segmentation:
by Sample Type
• Blood
• Saliva
• Tissue
• Bone Marrow
by Product Type
• Kits
• Laboratory Developed Tests (LDT)
• Reagents
by Origin
• Somatic Disorders
• Inherited Disorders
by Disorder Type
• Developmental Disorders
• Neurological Disorders
• Cardiovascular Disorders
• Others
Chapter 5A. Regional Segmentation
The Paediatric Genetic Testing Market has been analysed by studying the following regions:
North America
• by Sample Type
• by Product Type
• by Origin
• by Disorder Type
Europe
• by Sample Type
• by Product Type
• by Origin
• by Disorder Type
APAC
• by Sample Type
• by Product Type
• by Origin
• by Disorder Type
LatAm
• by Sample Type
• by Product Type
• by Origin
• by Disorder Type
MEA
• by Sample Type
• by Product Type
• by Origin
• by Disorder Type
**The Regions are further studied to analyse the major countries within the respective regions. The coverage of the country level data is dynamic and is updated regularly based on the market movements. Normally, the countries covered in the report include:
• North America - United States, Canada, Mexico;
• Europe - United Kingdom, France, Italy, Germany, Spain, Rest of Europe;
• Asia Pacific - China, India, Japan, South Korea, Rest of APAC;
• Middle East & Africa - South Africa, GCC Countries, Rest of MEA;
• Latin America - Brazil, Argentina, Rest of LatAm;
Chapter 6. Market Use case studies
Chapter 7. KOL Recommendations
Chapter 8. Investment Landscape
8.1 Paediatric Genetic Testing Market Investment Analysis
8.2 Market M&A
8.3 Market Fund Raise & Other activity
Chapter 9. Paediatric Genetic Testing Market - Competitive Intelligence
9.1 Company Positioning Analysis
9.1.1 Positioning - By Revenue
9.1.2 Positioning - By Business Score
9.1.3 Legacy Positioning
9.2 Competitive Strategy Analysis
9.2.1 Organic Strategies
9.2.2 Inorganic Strategies
Chapter 10. Key Company Profiles
*The Paediatric Genetic Testing Market Report profiles companies based on the material impact they have on the market ecosystem. These are hence, to be read as 'Key Players' and not necessarily 'Market Leaders'.
Companies are typically profiled to include:
10.x.1 Company Fundamentals
10.x.2 Performance Overview
10.x.3 Product Overview
10.x.4 Recent Developments
Key Companies profiled in this report include:
• Abbott Laboratories
• Agilent Technologies, Inc.
• BGI Genomics
• Baebies
• CENTOGENE AG
• Fulgent Genetics, Inc.
• Genomic Diagnostics
• Invitae Corporation
• LifeCell International Pvt. Ltd.
• OPKO Health, Inc.
• PerkinElmer, Inc.
• Quest Diagnostics
• Thermo Fisher Scientific Inc.
• Trivitron Healthcare
• Unilabs
Chapter 11. Appendix
11.1 About AllTheResearch (ATR)
11.2 ATR Services
11.3 Author details
11.4 Terms & Conditions
11.5 Contact us